IP Library Granted Patent US 7,425,319
Granted Patent B2
US 7,425,319 · App. 10/256,403 · Granted Sep 16, 2008

Method for enhancing protective cellular responses to genotoxic stress in skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,425,319
App. No.
10/256,403
Granted
Sep 16, 2008
Kind
B2
Abstract

The present invention is directed to methods of using pro-NAD agents capable of enhancing the dermal and epidermal skin cell NAD content. These pro-NAD agents may be administered topically, orally, or parenterally to enhance DNA repair and other protective responses to DNA damage. The invention further relates to pharmaceutical compositions comprising pro-NAD agents that effectively elevate intracellular NAD content. Finally, the invention relates to the method of using the pro-NAD agents to treat disorders such as sunburn and other skin deterioration that results from DNA damage in skin cells.

Claims (16)

1. A composition for increasing intracellular NAD content, comprising a hexadecyl nicotinic acid ester, tocopheryl acetate and a pharmaceutically acceptable carrier.

2. The composition of claim 1 , wherein said hexadecyl nicotinic acid ester is presented in said composition at from about 0.001% to about 10% by weight of said composition.

3. The composition of claim 2 , wherein said hexadecyl nicotinic acid ester is present in said composition at from about 0.01% to about 3% by weight of said composition.

4. The composition of claim 3 , wherein said hexadecyl nicotinic acid ester is present in said composition at about 1% by weight of said composition.

5. A composition for increasing intracellular NAD content comprising:

(i) a hexadecyl nicotinic acid ester;

(ii) an antioxidant, a sun screen, a vitamin or a pH stabilizer;

(iii) tocopheryl acetate, and

(iv) a pharmaceutically acceptable carrier.

6. The composition of claim 5 , wherein (ii) is an antioxidant.

7. The composition of claim 5 , wherein (ii) is a sun screen.

8. The composition of claim 5 , wherein (ii) is a vitamin.

9. The composition of claim 5 , wherein (ii) is a pH stabilizer.

10. The composition of claim 5 , wherein (i) is present at from about 0.001% to about 10% by weight of said composition.

11. The composition of claim 10 , wherein (i) is present at from about 0.01% to about 3% by weight of said composition.

12. The composition of claim 11 , wherein (i) is present at about 1% by weight of said composition.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: BLUE TORCH FINANCE LLC
To: NIADYNE, INC.
Reel/Frame 057535/0177 →
RELEASE OF COLLATERAL ASSIGNMENT (PATENTS) Recorded Jun 17, 2019
From: DEM HOLDINGS, L.P.
To: NIADYNE, INC.
Reel/Frame 049485/0895 →
ASSIGNMENT FOR SECURITY -- PATENTS Recorded Jun 17, 2019
From: NIADYNE, INC.
To: BLUE TORCH FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 049494/0669 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2019
From: DEM HOLDINGS, L.P., AS AGENT FOR LENDERS
To: NIADYNE, INC.
Reel/Frame 049451/0560 →
SECURITY INTEREST Recorded Oct 20, 2016
From: NIADYNE, INC.
To: DEM HOLDINGS, L.P.
Reel/Frame 040075/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2009
From: JACOBSON, ELAINE L.; JACOBSON, MYRON K.
To: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Reel/Frame 022793/0594 →